Citadel Advisors LLC 13D and 13G filings for Mereo BioPharma Group plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 06:19 am Sale |
2021-12-31 | 13G | Mereo BioPharma Group plc MREO |
Citadel Advisors LLC | 20,081,572 3.700% |
-10,848,814 (-35.07%) |
Filing |
| 2021-02-16 4:30 pm Sale |
2020-12-31 | 13G | Mereo BioPharma Group plc MREO |
Citadel Advisors LLC | 30,930,386 8.900% |
-202,605 (-0.65%) |
Filing |
| 2020-07-10 4:02 pm Purchase |
2020-07-01 | 13G | Mereo BioPharma Group plc MREO |
Citadel Advisors LLC | 31,132,991 8.900% |
31,132,991 (New Position) |
Filing |